RNF141 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.602400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.312400E-01
Normal-vs-Stage2
6.965800E-01
Normal-vs-Stage3
2.030600E-01
Normal-vs-Stage4
9.456000E-01
Stage1-vs-Stage2
7.162600E-01
Stage1-vs-Stage3
2.653000E-01
Stage1-vs-Stage4
8.671600E-01
Stage2-vs-Stage3
2.002200E-01
Stage2-vs-Stage4
5.649000E-01
Stage3-vs-Stage4
2.350600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.406600E-01
Normal-vs-AfricanAmerican
8.218200E-01
Normal-vs-Asian
6.325800E-01
Caucasian-vs-AfricanAmerican
8.247400E-01
Caucasian-vs-Asian
8.109200E-01
AfricanAmerican-vs-Asian
7.686800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.226000E-01
Normal-vs-Female
5.877200E-01
Male-vs-Female
4.852800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.103800E-01
Normal-vs-Age(41-60Yrs)
9.262200E-01
Normal-vs-Age(61-80Yrs)
5.528000E-01
Normal-vs-Age(81-100Yrs)
6.981000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.262200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.942800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.708400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.315700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.476200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.165200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.520000E-01
Normal-vs-Daily Drinker
5.462600E-01
Normal-vs-Weekly Drinker
2.579000E-01
Normal-vs-Occasional Drinker
6.627400E-01
Normal-vs-Social Drinker
9.464800E-01
Non Drinker-vs-Daily Drinker
7.696200E-01
Non Drinker-vs-Weekly Drinker
2.265400E-01
Non Drinker-vs-Occasional Drinker
7.086000E-02
Non Drinker-vs-Social Drinker
4.696200E-01
Daily Drinker-vs-Weekly Drinker
3.405600E-01
Daily Drinker-vs-Occasional Drinker
4.749700E-02
Daily Drinker-vs-Social Drinker
3.403600E-01
Weekly Drinker-vs-Occasional Drinker
1.062010E-02
Weekly Drinker-vs-Social Drinker
8.959800E-02
Occasional Drinker-vs-Social Drinker
3.627600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.943500E-02
Normal-vs-Grade 2
1.736300E-02
Normal-vs-Grade 3
1.035700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.310100E-02
Grade 1-vs-Grade 3
8.360000E-03
Grade 1-vs-Grade 4
6.943500E-02
Grade 2-vs-Grade 3
1.734560E-01
Grade 2-vs-Grade 4
1.736300E-02
Grade 3-vs-Grade 4
1.035700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.405000E-01
Normal-vs-NonDiabetic
5.739200E-01
Diabetic-vs-NonDiabetic
7.999200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.012000E-01
Normal-vs-NoPancreatitis
5.921600E-01
Pancreatitis-vs-NoPancreatitis
5.680000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.436800E-01
Normal-vs-N1
6.333600E-01
N0-vs-N1
6.911800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.619400E-01
Normal-vs-TP53-NonMutant
8.090600E-01
TP53-Mutant-vs-TP53-NonMutant
2.265800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
